Especially given that the system provided high probabilities of activated TGF-β signalling in some areas containing tumour cells with less p-SMAD2 (a-1 and a-6 in Fig. 3c), our diagnostic system could identify the possibility that tumour cells in those areas have acquired malignant phenotypes induced by TGF-β. The gene discussed is SMAD2; the disease is neoplasm.